Literature DB >> 17653765

Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression.

Chul-Kee Park1, Jin Hyun Kim, Min Jeong Moon, Ji Hye Jung, Su-Young Lim, Sung-Hye Park, Jong-Hoon Kim, Dong Gyu Kim, Hee-Won Jung, Byung-Kyu Cho, Sun Ha Paek.   

Abstract

PURPOSE: Frozen tumor tissues from a patient who showed rapid progression to anaplastic oligodendroglioma after near total resection of oligodendroglioma were used to examine differential expression of proteins to gain better understanding of the pathogenesis of malignant transformation.
METHODS: We have determined their protein profiles using a 2D gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry approach.
RESULTS: Among 23 differentially expressed spots, overexpression of peroxiredoxin 6 and underexpression of rho GDP dissociation inhibitor alpha were confirmed to be valid after western blot and immunocytochemical analysis of oligodendroglioma tissue.
CONCLUSIONS: Abnormal expression of peroxiredoxin 6 and rho GDP dissociation inhibitor alpha may be associated with malignant transformation in oligodendroglioma and these proteins might be candidates of molecular predictive factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653765     DOI: 10.1007/s00432-007-0282-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

Authors:  A J Ridley; H F Paterson; C L Johnston; D Diekmann; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Proteomic studies on low- and high-grade human brain astrocytomas.

Authors:  Federico Odreman; Marco Vindigni; Marlen Lujardo Gonzales; Benedetta Niccolini; Giovanni Candiano; Bruno Zanotti; Miran Skrap; Stefano Pizzolitto; Giorgio Stanta; Alessandro Vindigni
Journal:  J Proteome Res       Date:  2005 May-Jun       Impact factor: 4.466

3.  Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.

Authors:  K Hoang-Xuan; J He; S Huguet; K Mokhtari; Y Marie; M Kujas; P Leuraud; L Capelle; J Y Delattre; J Poirier; P Broët; M Sanson
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

4.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

5.  Molecular genetic analysis of non-astrocytic gliomas.

Authors:  C Y Tong; H K Ng; J C Pang; A B Hui; H C Ko; J C Lee
Journal:  Histopathology       Date:  1999-04       Impact factor: 5.087

6.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.

Authors:  J Reifenberger; G Reifenberger; L Liu; C D James; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 7.  Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung.

Authors:  Vuokko L Kinnula; Paavo Pääkkö; Ylermi Soini
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

8.  Oligodendrogliomas: the Mayo Clinic experience.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon; H D Tazelaar; D H Davis
Journal:  J Neurosurg       Date:  1992-03       Impact factor: 5.115

9.  Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues.

Authors:  H J Kim; H Z Chae; Y J Kim; Y H Kim; T S Hwangs; E M Park; Y M Park
Journal:  Cell Biol Toxicol       Date:  2003-10       Impact factor: 6.691

10.  Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.

Authors:  Wen G Jiang; Gareth Watkins; Jane Lane; Giles H Cunnick; Anthony Douglas-Jones; Kefah Mokbel; Robert E Mansel
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

View more
  6 in total

1.  Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling.

Authors:  Nigar Fatma; Eri Kubo; Yoshihiro Takamura; Keiichi Ishihara; Claudia Garcia; David C Beebe; Dhirendra P Singh
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

Review 2.  Proteomics of gliomas: initial biomarker discovery and evolution of technology.

Authors:  Juliya Kalinina; Junmin Peng; James C Ritchie; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2011-09       Impact factor: 12.300

3.  Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPase.

Authors:  Xinhua Li; Alan Yiu Wah Lee
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

4.  Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.

Authors:  Abhilash Venugopal; Raghothama Chaerkady; Akhilesh Pandey
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

Review 5.  The Roles of Peroxiredoxin 6 in Brain Diseases.

Authors:  Jiangfeng Liao; Yusi Zhang; Xiaochun Chen; Jing Zhang
Journal:  Mol Neurobiol       Date:  2021-05-19       Impact factor: 5.590

6.  Proteomic profiling of follicular and papillary thyroid tumors.

Authors:  Anastasios Sofiadis; Susanne Becker; Ulf Hellman; Lina Hultin-Rosenberg; Andrii Dinets; Mykola Hulchiy; Jan Zedenius; Göran Wallin; Theodoros Foukakis; Anders Höög; Gert Auer; Janne Lehtiö; Catharina Larsson
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.